Nature of Organization and Operations (Detail) - USD ($) $ in Thousands			3 Months Ended	12 Months Ended		33 Months Ended	34 Months Ended
	Mar. 25, 2025	Mar. 04, 2025	Mar. 26, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2024	Dec. 19, 2024	Mar. 17, 2022
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Accumulated deficit				$ 332,654	$ 268,963	$ 332,654	$ 332,654
Net loss				63,691	$ 65,765
Cash, cash equivalents, and short-term investments				$ 47,200		$ 47,200	$ 47,200
Subsequent Event
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Increase in cash, cash equivalents, and short-term investments			$ 202,400
Subsequent Event \| Private Placement
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Sale of stock, consideration received on transaction, gross		$ 100,000
Sales Agreement
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Issuance of common stock to PIPE Investors, net of issuance costs (in shares)							0
Sales Agreement \| Cowen and Company LLC \| Common Stock
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Maximum aggregate offering prices									$ 75,000
Issuance of common stock to PIPE Investors, net of issuance costs (in shares)						0
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement \| WuXi Biologics
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Non-refundable payment due								$ 38,000
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement \| WuXi Biologics \| Subsequent Event
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Non-refundable payment due			$ 38,000
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations \| Aadi Subsidiary
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Disposal group, including discontinued operation, ownership percentage in disposed business								100.00%
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations \| Aadi Subsidiary \| Subsequent Event
Organization Consolidation And Presentations Of Financial Statements [Line Items]
Proceeds from divestiture of businesses	$ 102,400

Whitehawk Therapeutics, Inc. 10-K